drugset / Trial / NCT03300518

Effectiveness of Estradiol Valerate Pretreatment in Antagonist Protocol for Poor Ovarian Response Patient

NCT03300518 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of study is to assess the efficacy of add-on estrogen pretreatment in GnRH antagonist protocol on oocyte retrieval as compared with GnRH antagonist protocol for patients with poor ovarian response Add-on estrogen pretreatment protocol is superior to none pretreatment GnRH antagonist protocol for the number of oocytes retrieval

Timeline

Start
2017-11-15
Primary completion
2021-06-18
Completion
2021-08-18

Outcome

Missed primary endpoint

paper The treatment difference was -0.18 (95% CI -0.67, 0.32, P = 0.49). PMID 35460400 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject estradiol valerate Unknown 2 mg Oral
Background Follitropin beta Protein / enzyme biologic 300 iu Subcutaneous
Background Ganirelix Protein / enzyme biologic 0.25 mg —
Background hCG Unknown 10000 iu —

Indications